{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:50:46Z","timestamp":1761519046069},"reference-count":20,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2012,7,11]],"date-time":"2012-07-11T00:00:00Z","timestamp":1341964800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0039222","type":"journal-article","created":{"date-parts":[[2012,7,11]],"date-time":"2012-07-11T21:08:13Z","timestamp":1342040893000},"page":"e39222","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["96 Week Follow-Up of HIV-Infected Patients in Rescue with Raltegravir Plus Optimized Backbone Regimens: A Multicentre Italian Experience"],"prefix":"10.1371","volume":"7","author":[{"given":"Amedeo","family":"Capetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Landonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Meraviglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Di Biagio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Lo Caputo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetana","family":"Sterrantino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Ammassari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Menzaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Franzetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe Vittorio","family":"De Socio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Pellican\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Mazzotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Soria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Meschiari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Trezzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lolita","family":"Sasset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedetto Maurizio","family":"Celesia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Zucchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Melzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliano","family":"Rizzardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,7,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0140-6736(07)60597-2","article-title":"Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial.","volume":"369","author":"B Grinsztejn","year":"2007","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1086\/650002","article-title":"Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials.","volume":"(4)","author":"RT Steigbigel","year":"2010","journal-title":"Clin Infect Dis 50"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/jac\/dkp114","article-title":"Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort.","volume":"(6)","author":"L Wittkop","year":"2009","journal-title":"J Antimicrob Chemother 63"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/QAI.0b013e3181ba4845","article-title":"A single-center cohort experience of raltegravir in salvage patients failing therapy.","volume":"53(5)","author":"A Teague","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2147\/CLEP.S10478","article-title":"Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen.","volume":"2","author":"FN Engsig","year":"2010","journal-title":"Clinical Epidemiology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3109\/00365541003621502","article-title":"Raltegravir as functional monotherapy leads to virological failure and drug resistance in highly treatment-experienced HIV-infected patients.","volume":"(6\u20137)","author":"F Caby","year":"2010","journal-title":"Scand J Infect Dis 42"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/QAD.0b013e3283372d76","article-title":"Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience.","volume":"(6)","author":"S Nozza","year":"2010","journal-title":"AIDS 24"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1086\/630210","article-title":"High rate of virologic suppression with raltegravir plus etravirine and darunavir\/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO trial.","volume":"(9)","author":"Y Yazdanpanah","year":"2009","journal-title":"Clin Infect Dis 49"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/157016211794582650","article-title":"Long-term safety from the raltegravir clinical development program.","volume":"(1)","author":"H Teppler","year":"2011","journal-title":"Curr HIV Res 9"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jinf.2010.04.011","article-title":"Severe acute renal failure associated with rhabdomyolysis during treatment with raltegravir. A call for caution.","volume":"61","author":"M Masi\u00e1","year":"2010","journal-title":"J Infect"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1097\/QAD.0b013e32833fca42","article-title":"Raltegravir-induced cerebellar ataxia.","volume":"24","author":"KA Reiss","year":"2010","journal-title":"AIDS"},{"key":"ref12","article-title":"CTCAE website."},{"key":"ref13","article-title":"Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/QAI.0b013e31824bb720","article-title":"Long-term efficacy and safety of raltegravir, etravirine and darunavir\/ritonavir in treatment-experienced patients: week 96 results from the ANRS 139 Trio Trial.","volume":"(5)","author":"C Fagard","year":"2012","journal-title":"J Acquir Immune Defic Syndr 59"},{"key":"ref15","first-page":"543","article-title":"Hepatic safety profile of raltegravir in HIV-infected patients with chronic hepatitis C. J Antimicrob Chemother 65","volume":"(3)","author":"E Vispo","year":"2010"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1310\/hct1105-260","article-title":"A pilot study of abacavir\/lamivudine and raltegravir in antiretroviral-na\u00efve HIV-1-infected patients: 48-week results of the SHIELD trial.","volume":"11(5)","author":"B Young","year":"2010","journal-title":"HIV Clin Trials"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1097\/QAD.0b013e32833a608a","article-title":"Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study.","volume":"(11)","author":"E Mart\u00ednez","year":"2010","journal-title":"AIDS 24"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1001\/jama.289.22.2978","article-title":"Impact of HIV infection and HAART on serum lipids in men.","volume":"(22)","author":"SA Riddler","year":"2003","journal-title":"JAMA 289"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.biopha.2007.07.012","article-title":"Cholesterol levels in HIV-HCV infected patients treated with lopinavir\/r: results from the SCOLTA project.","volume":"(1)","author":"GV De Socio","year":"2008","journal-title":"Biomed Pharmacother 62"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/QAI.0b013e31818c7e8e","article-title":"Is dual therapy with raltegravir and protease inhibitors a feasible option in rescue strategy in HIV-1 infection?","volume":"(2)","author":"AF Capetti","year":"2009","journal-title":"J Acquir Immune Defic Syndr 50"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0039222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T01:08:11Z","timestamp":1539997691000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0039222"}},"subtitle":[],"editor":[{"given":"Cecilio","family":"L\u00f3pez-Gal\u00edndez","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,7,11]]},"references-count":20,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,7,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0039222","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,11]]}}}